Strain Information | |
---|---|
Image | |
BRC No. | RBRC02475 |
Type | Targeted Mutation Congenic![]() |
Species | Mus musculus |
Strain name | B6.Cg-Hras1<tm1Mok> Nras<tm1Mok> Il6st<tm1> |
Former Common name | B6-Hras/Nras/gp130 KO |
H-2 Haplotype | |
ES Cell line | |
Background strain | |
Appearance | |
Strain development | Developed by Motoya Katsuki, National Institutes of Natural Sciences. |
Strain description | Hras, Nras and gp130 (Il6st) genes triple knockout mice. |
Colony maintenance | |
References | Targeted deletion of the H-ras gene decreases tumor formation in mouse skin carcinogenesis. Ise K, Nakamura K, Nakao K, Shimizu S, Harada H, Ichise T, Miyoshi J, Gondo Y, Ishikawa T, Aiba A, Katsuki M Oncogene, 19(26):2951-2956 (2000). 10871846K-Ras mediates cytokine-induced formation of E-cadherin-based adherens junctions during liver development. Matsui T, Kinoshita T, Morikawa Y, Tohya K, Katsuki M, Ito Y, Kamiya A, Miyajima A EMBO J. 21(5):1021-30 (2002). 11867530 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
Il6st MGI:96560 | interleukin 6 signal transducer | 13 | Il6st<tm1> | targeted mutation 1 | |||
Csde1 MGI:92356 | cold shock domain containing E1, RNA binding | 3 | Csde1 | ||||
Nras MGI:97376 | neuroblastoma ras oncogene | 3 | Nras<tm1Mok> MGI:3794957 | targeted mutation 1, Motoya Katsuki | |||
neo | neomycin resistance gene (E. coli) | 3 | herpes simplex virus thymidine kinase promoter (HSV tk promoter) | ||||
Hras MGI:96224 | Harvey rat sarcoma virus oncogene | 7 | Hras<tm1Mok> MGI:2386128 | targeted mutation 1, Motoya Katsuki | |||
neo | neomycin resistance gene (E. coli) | 7 |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | E. coli neo, mouse H-ras genomic DNA, mouse N-ras genomic DNA, mouse gp130 genomic DNA |
Research application | Immunology and Inflammation Research covid19_onset |
Specific Term and Conditions | In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Oncogene, 19, 2951-2956 (2000). EMBO J., 21, 1021-1030 (2002).In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to Dr. Motoya Katsuki is requested. The RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. |
Depositor | Toshikuni Sasaoka (Niigata University) |
Strain Status | ![]() |
Strain Availability | ![]() |
Additional Info. | Necessary documents for ordering: |
BRC mice in Publications |
---|
No Data |